Co‐morbid OSA and insomnia increases depression prevalence and severity in men. Issue 7 (7th June 2017)

• Record Type: Journal Article
• Authors: Lang, Carol J.; Appleton, Sarah L.; Vakulin, Andrew; M Evoy, R. Doug; Wittert, Gary A.; Martin, Sean A.; Catcheside, Peter G.; Antic, Nicholas A.; Lack, Leon; Adams, Robert J.
• Is Part Of: Respirology. Volume 22:Issue 7(2017)
• Page Start: 1407
• Page End: 1415
• Publication Date: 2017-06-07
• Subjects: depression -- insomnia -- obstructive sleep apnoea -- population study -- prevalence; Respiratory organs -- Diseases -- Periodicals; Respiratory organs -- Periodicals; 612.2
• DOI: 10.1111/resp.13064
• Languages: English
• ISSNs: 1323-7799

Abstract

ABSTRACT: Background and objective: Obstructive sleep apnoea (OSA) and insomnia coexist in clinical populations but prevalence in the community and risk factors remain largely unknown. We examined the prevalence and profile of previously undiagnosed co‐morbid OSA and insomnia symptoms (COMISA) in community‐dwelling men. Methods: Men ( n = 700, aged 58.5 ± 11.0 (mean ± SD) years) without a prior diagnosis of OSA completed full at‐home unattended polysomnography, the Pittsburgh Sleep Quality Index and 36‐item short form (SF‐36) survey (2007–2012). Insomnia symptoms included difficulty initiating/maintaining sleep in the presence of daytime fatigue (DIMS‐F). Depressive symptoms were assessed using the Beck Depression Inventory‐1A, Centre for Epidemiological Studies Depression Scale and Patient Health Questionnaire‐9 (PHQ‐9) (2007–2010). Univariate (χ 2 and analysis of variance (ANOVA)) and multiple linear regressions were used to compare data from four groups of individuals: neither disorder; previously undiagnosed OSA (apnoea–hypopnoea index ≥ 10) or DIMS‐F alone; and COMISA. Results: COMISA prevalence was 6.7%. Depression prevalence (COMISA, 42.6%; DIMS‐F, 21.6%; OSA, 8.4%, χ 2 = 71.6, P < 0.00) and symptom scale scores (e.g. PHQ‐9 mean ± SD: 16.1 ± 5.5 c.f. DIMS‐F: 14.0 ± 4.9, P < 0.01 and OSA: 11.4 ± 3.0, P = 0.01) were highest in men with COMISA. In COMISA, respiratory and arousal indices were similar to those observed in OSA whilst reductions in subjective sleep and day dysfunction scores were similar to DIMS‐F. After adjustment, predicted mean depression scores were all higher in DIMS‐F and COMISA using linear regression (e.g. PHQ‐9 β (95% CI): DIMS‐F: 2.3 (1.2, 3.5); COMISA: 4.1 (3.0, 5.1)). Conclusion: Men with COMISA have a greater prevalence, and severity, of depression than men with only one disorder. Abstract : We investigated the prevalence and clinical profile of previously undiagnosed co‐morbid obstructive sleep apnoea (OSA) and insomnia symptoms (COMISA) in men. Men with COMISA have a higher prevalence, and severity, of depressive symptoms than men with OSA or insomnia symptoms alone. This has implications when planning how to identify and treat COMISA in the community. See related Article